Universal Biosensors Inc Total Assets
Universal Biosensors Inc total assets. Based on the latest financial reports, Universal Biosensors Inc (UBI) holds total assets worth AU$14.94 Million AUD (≈ $10.57 Million USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Universal Biosensors Inc market capitalisation for the company's overall valuation and market capitalisation.
Total Assets of Universal Biosensors Inc (2002–2024)
Total assets of Universal Biosensors Inc from 2002 to 2024. This chart illustrates how Universal Biosensors Inc's total assets have evolved over time, based on quarterly financial data. See Universal Biosensors Inc (UBI) share price today for real-time trading data and today's change.
Universal Biosensors Inc - Asset Composition Analysis
Universal Biosensors Inc Total Assets Breakdown (December 2024)
Universal Biosensors Inc total assets breakdown as of December 2024. Universal Biosensors Inc's total assets of AU$14.94 Million consist of 71.5% current assets and 28.5% non-current assets.
| Asset Category | Amount (AUD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$8.54 Million | 33.1% |
| Accounts Receivable | AU$3.14 Million | 12.2% |
| Inventory | AU$5.59 Million | 21.6% |
| Property, Plant & Equipment | AU$6.95 Million | 26.9% |
| Intangible Assets | AU$0.00 | 0.0% |
| Goodwill | AU$0.00 | 0.0% |
Asset Composition Trend (2002–2024)
This chart illustrates how Universal Biosensors Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Universal Biosensors Inc current assets vs equity to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Universal Biosensors Inc's current assets represent 71.5% of total assets in 2024, an increase from 0.0% in 2002.
- Cash Position: Cash and equivalents constituted 33.1% of total assets in 2024, up from 32.2% in 2002.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2002.
- Asset Diversification: The largest asset category is cash and equivalents at 33.1% of total assets.
Universal Biosensors Inc Competitors by Total Assets
Key competitors of Universal Biosensors Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Cochlear Ltd
AU:COH
|
Australia | AU$2.83 Billion |
|
Vitrolife AB
ST:VITR
|
Sweden | Skr11.30 Billion |
|
Sinocare Inc
SHE:300298
|
China | CN¥6.25 Billion |
|
Shanghai Sanyou Medical Co Ltd
SHG:688085
|
China | CN¥2.34 Billion |
|
Zhejiang Orient Gene Biotech Co Ltd
SHG:688298
|
China | CN¥7.51 Billion |
|
Nanjing Vishee Medical Technology Co Ltd
SHG:688580
|
China | CN¥1.79 Billion |
|
TAIDOC TECHNOLOGY CORP
TW:4736
|
Taiwan | NT$13.07 Billion |
|
SS Innovations International Inc. Common Stock
NASDAQ:SSII
|
USA | $96.98 Million |
Universal Biosensors Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.90 | 5.65 | 3.03 |
| Quick Ratio | 1.13 | 4.45 | 2.84 |
| Cash Ratio | 0.52 | 0.00 | 0.00 |
| Working Capital | AU$3.81 Million | AU$21.00 Million | AU$21.93 Million |
Universal Biosensors Inc - Advanced Valuation Insights
This section examines the relationship between Universal Biosensors Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.59 |
| Latest Market Cap to Assets Ratio | 0.11 |
| Asset Growth Rate (YoY) | -13.8% |
| Total Assets | AU$25.84 Million |
| Market Capitalization | $2.95 Million USD |
Valuation Analysis
Below Book Valuation: The market values Universal Biosensors Inc's assets below their book value (0.11x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Universal Biosensors Inc's assets decreased by 13.8% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Universal Biosensors Inc (2002–2024)
The table below shows the annual total assets of Universal Biosensors Inc from 2002 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | AU$25.84 Million ≈ $18.28 Million |
-13.79% |
| 2023-12-31 | AU$29.97 Million ≈ $21.21 Million |
-35.05% |
| 2022-12-31 | AU$46.15 Million ≈ $32.65 Million |
+3.69% |
| 2021-12-31 | AU$44.50 Million ≈ $31.49 Million |
-21.07% |
| 2020-12-31 | AU$56.38 Million ≈ $39.89 Million |
-10.02% |
| 2019-12-31 | AU$62.66 Million ≈ $44.34 Million |
-10.46% |
| 2018-12-31 | AU$69.98 Million ≈ $49.51 Million |
+51.26% |
| 2017-12-31 | AU$46.26 Million ≈ $32.73 Million |
-7.46% |
| 2016-12-31 | AU$49.99 Million ≈ $35.37 Million |
+11.21% |
| 2015-12-31 | AU$44.95 Million ≈ $31.81 Million |
-5.43% |
| 2014-12-31 | AU$47.53 Million ≈ $33.63 Million |
-12.98% |
| 2013-12-31 | AU$54.62 Million ≈ $38.65 Million |
+11.32% |
| 2012-12-31 | AU$49.07 Million ≈ $34.72 Million |
+8.52% |
| 2011-12-31 | AU$45.22 Million ≈ $31.99 Million |
-16.01% |
| 2010-12-31 | AU$53.84 Million ≈ $38.09 Million |
-4.00% |
| 2009-12-31 | AU$56.08 Million ≈ $39.68 Million |
+2.55% |
| 2008-12-31 | AU$54.69 Million ≈ $38.69 Million |
-14.36% |
| 2007-12-31 | AU$63.86 Million ≈ $45.18 Million |
+60.11% |
| 2006-12-31 | AU$39.88 Million ≈ $28.22 Million |
+823.84% |
| 2005-12-31 | AU$4.32 Million ≈ $3.05 Million |
+2.01% |
| 2004-12-31 | AU$4.23 Million ≈ $2.99 Million |
+1.39% |
| 2003-12-31 | AU$4.17 Million ≈ $2.95 Million |
+168.94% |
| 2002-12-31 | AU$1.55 Million ≈ $1.10 Million |
-- |
About Universal Biosensors Inc
Universal Biosensors, Inc., through its subsidiaries, designs and develops electrochemical cells (strips) used in conjunction with point-of-use devices in Australia, the Americas, Europe, and internationally. The company manufactures and distributes Prothrombin Time International Normalized Ratio coagulation test strips and Xprecia Stride and Xprecia Prime medical devices to monitor the effect of… Read more